Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation
Over a half century, organ transplantation has become an effective method for the treatment of end-stage visceral diseases. Although the application of immunosuppressants (IS) minimizes the rate of allograft rejection, the common use of IS bring many adverse effects to transplant patients. Moreover,...
Main Authors: | Quan Zhuang, Haozheng Cai, Qingtai Cao, Zixin Li, Shu Liu, Yingzi Ming |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.552988/full |
Similar Items
-
Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials
by: Aurelie eMoreau, et al.
Published: (2012-08-01) -
Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity
by: Matthias P. Domogalla, et al.
Published: (2017-12-01) -
Make immunological peace not war: Potential applications of tolerogenic dendritic cells
by: Emma Louise Walton
Published: (2017-04-01) -
Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
by: Eros Marín, et al.
Published: (2018-02-01) -
Expression of tolerogenic potential-representing markers on clinical-grade therapeutic dendritic cell-based cancer vaccines
by: Neringa T. Dobrovolskienė, et al.
Published: (2014-02-01)